Abstract
Objective
Expansion of adipose tissue during obesity through the recruitment of newly generated adipocytes (hyperplasia) is metabolically healthy, whereas that through the enlargement of pre-existing adipocytes (hypertrophy) leads to metabolic complications. Accumulating evidence from genetic fate mapping studies suggests that in animal models receiving a high-fat diet (HFD), only adipocyte progenitors (APs) in gonadal white adipose tissue (gWAT) have proliferative potential. However, the proliferative potential and differentiating capacity of APs in the inguinal WAT (iWAT) of male mice remains controversial. The objective of this study was to investigate the proliferative and adipogenic potential of APs in the iWAT of HFD-fed male mice.
Methods
We generated PDGFRα-GFP-Cre-ERT2/tdTomato (KI/td) mice and traced PDGFRα-positive APs in male mice fed HFD for 8 weeks. We performed a comprehensive phenotypic analysis, including the histology, immunohistochemistry, flow cytometry, and gene expression analysis, of KI/td mice fed HFD.
Results
Contrary to the findings of others, we found an increased number of newly generated tdTomato+ adipocytes in the iWAT of male mice, which was smaller than that observed in the gWAT. We found that in male mice, the iWAT has more proliferating tdTomato+ APs than the gWAT. We also found that tdTomato+ APs showed a higher expression of Dpp4 and Pi16 than tdTomato− APs, and the expression of these genes was significantly higher in the iWAT than in the gWAT of mice fed HFD for 8 weeks. Collectively, our results reveal that HFD feeding induces the proliferation of tdTomato+ APs in the iWAT of male mice.
Conclusion
In male mice, compared with gWAT, iWAT undergoes hyperplasia in response to 8 weeks of HFD feeding through the recruitment of newly generated adipocytes due to an abundance of APs with a high potential for proliferation and differentiation.
Keywords: Adipocyte hyperplasia, Obesity, Adipogenesis, Adipocyte progenitors
Graphical abstract
Highlights
-
•
High-fat diet (HFD) increases proliferative APs in iWAT of male mice.
-
•
HFD promotes the recruitment of smaller adipocytes in the iWAT of male mice.
-
•
iWAT expands by recruiting newly-generated adipocytes (hyperplasia) in male mice.
-
•
gWAT expands by enlargement of pre-existing adipocytes (hypertrophy) in male mice.
Abbreviations
- WAT
White Adipose Tissue
- gWAT
Visceral or Gonadal WAT
- eWAT
Epididymal WAT
- iWAT
Subcutaneous or Inguinal WAT (iWAT)
- APs
Adipocyte Progenitors
- HFD
High Fat Diet
- NC
Normal Chow
- BW
Body Weight
- PDGFRα
Platelet-derived Growth Factor Receptor-alpha
- KI/+
PDGFRα-GFP-Cre-ERT2 knock-in
- KI/td
PDGFRα-GFP-Cre-ERT2/tdTomato mice
- TAM
Tamoxifen
- FACS
Fluorescence-activated Cell Sorting
- WT
Wild-type
1. Introduction
Obesity is characterized by the expansion of white adipose tissue (WAT) in response to HFD feeding, either by the enlargement of the existing adipocytes (hypertrophy) or through the recruitment of new adipocytes (hyperplasia) [[1], [2], [3], [4], [5]]. Several studies have shown that the imbalance between adipocyte hypertrophy and hyperplasia in WAT depots is associated with metabolic disturbances, including insulin resistance, cardiometabolic risk, dyslipidemia, and atherosclerosis [[4], [5], [6], [7], [8], [9], [10], [11], [12]].
WAT is mainly distributed in two major fat depots, namely visceral or gonadal WAT (gWAT) and subcutaneous or inguinal WAT (iWAT). To meet the energy balance during HFD intake, these depots can expand by up to 70% [[13], [14], [15]]. The expansion of iWAT is related to preserving insulin sensitivity, less inflammation and improving the metabolic profile, whereas gWAT expansion is associated with larger adipocytes and proinflammatory macrophages, leading to insulin resistance [[16], [17], [18], [19], [20], [21], [22]]. The expansion of WAT depots was found to occur in different patterns in males and females [6,23,24]. Joe et al. showed that only adipocyte progenitors (APs) in iWAT, and not in gWAT, exhibit proliferative potential in HFD-fed male mice [25]. In contrast, studies on lineage tracing using genetic mice models revealed that gWAT in adult male mice expands through adipocyte hyperplasia and hypertrophy, whereas iWAT expands exclusively through cellular hypertrophy under HFD-fed conditions [5,6,[26], [27], [28]]. How individual adipose depots expand by hypertrophy or hyperplasia, especially in HFD-fed male mice, is unknown.
Platelet-derived growth factor receptor-alpha (PDGFRα), a membrane-bound tyrosine kinase receptor that is expressed in different tissues during embryogenesis, is an ideal marker of APs [29]. Recent reports on single-cell RNA-sequencing analysis have revealed that WAT contains at least two major subtypes of APs, namely DPP4+ APs and ICAM-1+ APs. DPP4+ APs are highly proliferative, whereas ICAM-1+ APs are committed to an adipogenic fate [[30], [31], [32], [33]]. A recent report showed, using both Cre and Dre recombinase drivers, that PDGFRα single-positive APs and PDGFRα/PDGFRβ double-positive APs contributed to cold-induced beige adipogenesis whereas PDGFRβ single-positive APs did not, as observed in a mouse model. Moreover, PDGFRα single-positive APs highly expressed Dpp4 and Pi16 compared with PDGFRα/PDGFRβ double-positive APs, which highly expressed Lpl and Fabp4 and are committed to an adipogenic fate [34]. However, how these subtypes of APs contribute to adipogenesis under HFD-fed conditions remains unknown.
In this study, we used a PDGFRα-GFP-Cre-ERT2/tdTomato (KI/td) mouse model to investigate the role of PDGFRα+ APs in HFD-fed male mice. Contrary to other reports, our findings revealed that in male mice, iWAT expanded significantly through de novo adipogenesis. We found a higher number of tdTomato + APs and adipocytes in the iWAT than in the gWAT of male mice. Moreover, tdTomato + APs showed higher expression levels of Dpp4 and Pi16, and their expression was significantly higher in the iWAT than in the gWAT of HFD-fed male mice.
2. Materials and methods
2.1. Animals
2.1.1. Generation and housing of KI/td mice
All experimental and animal care procedures were approved by the Animal Experiment Committee of the University of Toyama (Approval number A2018med-142/A2018MED-52). We generated KI/td mice by crossing PDGFRα-GFP-Cre-ERT2 knock-in (KI/+) mice [35] with B6.Cg-Gt (ROSA)26Sortm9(CAG-td-Tomato)Hze/J mice [36]. Animals were maintained under a standard 12:12-hour light-dark cycle. Both male and female mice were used for the experiments. The mice had free access to NC (CE-2 CLEA, Japan) or HFD (60% Calories Fat Research Diets, Japan) and water. Body weight (BW) and food intake measurements were made in animals that were housed at 2–3 mice per cage.
2.2. Method details
2.2.1. Genotyping
Tail tissue was lysed with the Direct PCR (Tail) lysis solution (Viagen Biotech) and proteinase K (Roche Diagnostics), in accordance with the manufacturer's instructions, to obtain genomic DNA. PCR was performed with crude genomic DNA using the Tks Gflex DNA polymerase kit from TAKARA (Shiga, Japan).
For KI/+ mice, PCR conditions included one cycle at 94 °C for 2 min and 30 cycles at 98 °C for 10 s, 60 °C for 30 s, and 68 °C for 1 min. The following primers were purchased from Invitrogen™ Life Technology (Tokyo, Japan): 5′-WT: AAGACGATTCACACTGCCGATG, 3′-WT: AGACAGCTGAGGACCAGAAAGA, and 3′-KI: TGGTGCAGATGAACTTCAGGGT [35]. DNA fragment sizes were 525 bp for the KI allele and 388 bp for the WT allele. PCR conditions for B6.Cg-Gt (ROSA)26Sortm9(CAG-td-Tomato)Hze/J were as follows: one cycle at 94 °C for 2 min; 10 cycles at 94 °C for 20 s, 65 °C for 15 s (−0.5 °C each cycle), and 68 °C for 10 s; 28 cycles at 94 °C for 15 s, 60 °C for 15 s, and 72 °C for 10 s; one cycle at 72 °C for 2 min; and hold at 10 °C for infinity. The expected DNA fragment size was 200 bp for mutant mice and 297 bp for WT mice. The following primers were purchased from Invitrogen™ Life Technology (Tokyo, Japan): WT FW, AAGGGAGCTGCAGTGGAGTA; WT Rev, CCGAAAATCTGTGGGAAGTC; Mutant FW, CTGTTCCTG0TACGGCATGG; and Mutant Rev, GGCATTAAAGCAGCGTATCC. For KI/+ and tdTomato, PCR products were run on 2% and 1.5% agarose gels (Nippon Gene), respectively, for 30 min. Ethidium bromide (1:1000) was added to visualize DNA on the gel.
2.2.2. Tamoxifen administration
Tamoxifen (TAM; Sigma–Aldrich) was dissolved in sunflower oil (Fujifilm WAKO) and administered to KI/td mice orally at the age of 7 weeks for five consecutive days at 225 mg/kg BW, as described previously [36,37]. After a recovery period of one week, the mice were analyzed for recombination efficiency or fed either NC or HFD. Recombination efficiency was measured using the following formula for immunohistochemistry and FlowJo analysis for flow cytometry:
2.2.3. White adipose tissue depot collection
gWAT was clearly identified with forceps along the epididymis and testes in males (also known as epididymal or eWAT) and around the uterus and ovarian ducts in females.
iWAT depot was identified with forceps as extending from the hind limb ventrally to the groin area in both male and female mice, as demonstrated previously [38,39].
2.2.4. Weight of WAT as a percentage of BW
WAT weight as a percentage of BW was calculated using the formula given below:
2.2.5. Flow-cytometric analysis
The stromal cell suspension was prepared for flow cytometry, as described previously [[40], [41], [42], [43], [44]]. In brief, the tissue was digested in 2 mg/mL collagenase (Sigma) for 45 min at 37 °C and then filtered through a 100 μm cell strainer to collect single cells. For flow cytometry, the 7AAD− population was gated for further analysis of lineage negative (CD31−CD45−) populations, followed by the positive selection of Sca1+PDGFRα+tdTomato+ populations. Unstained, isotype controls and fluorescence minus one (FMO) were used for justification of the gating strategy. Experiments were performed on the BD FACS Aria™ II machine, and data were analyzed using the FlowJo offline software.
2.2.6. Immunohistochemistry
Hematoxylin and eosin (H&E) staining was performed on 5–10-μm-thick paraffin sections, as described previously [42], and images were taken using an Olympus microscope (Olympus, DP70). Immunohistochemical staining was performed using paraffin-embedded tissue sections, as described previously [42,43,45,46]. Primary and secondary antibodies were used in accordance with the manufacturer's instructions. Primary antibodies including guinea pig anti-GFP (1:200) (Frontier Institute), goat anti-tdTomato (1:150) (SICGEN), rabbit anti-RFP (mouse) (1:250) (Rockland), rabbit anti-Ki67 (1:100) (Abcam), and rabbit anti-perilipin (1:100) (Santa Cruz) antibodies were used. Secondary antibodies and DAPI (Molecular Probes) were used at 1:250 and 1:500 dilutions, respectively. All images were taken using a confocal microscope (Leica TCS-SP5) and the images were analyzed using the ImageJ software.
2.2.7. Percent de novo adipogenesis and Ki67-positive cells
Perilipin+ (green) adipocytes were considered as pre-existing adipocytes, whereas Perilipin+/tdTomato+ adipocytes (red or yellow) were considered as newly generated adipocytes. Cell counts to analyze de novo adipogenesis were determined through multi-point counting using the ImageJ software (confocal images included 5 randomly selected areas from one depot per slide per specimen, with 4–6 specimens under each condition). The percentages of proliferative APs (Ki67+/tdTomato+ cells) and newly generated adipocytes were calculated using the following formulae, respectively.
2.2.8. EdU staining
We injected EdU into 12-week HFD-fed KI/td male mice at 2 mg/kg BW. Three hours later, the mice were euthanized to harvest the tissues. Frozen sections of adipose tissue (35–40 μm thickness) were prepared, as described previously [42]. EdU immunostaining was performed using Alexa 555 and anti-RFP antibodies, followed by the secondary antibody. The percentage of EdU+ APs was calculated using the formula given below:
2.2.9. Adipocyte size measurement
The mean adipocyte number was counted using the multi-point tool in ImageJ 1.53a (National Institute of Health, USA). The adipocyte size was measured using the “Set Scale” function in ImageJ 1.53a from five random 20 × fields per specimen. We took one depot per slide per specimen and 4–6 specimens for each condition.
2.2.10. Real-time polymerase chain reaction
FACS-sorted cells were collected in RPMI buffer and stored in Isogen (Nippon Gene). The Qiagen RNeasy kit was used to extract RNA from the cells. The TaKaRa PrimeScript RNA Kit was used for reverse transcription, according to the manufacturer's instructions. The quantitative PCR amplification reaction was performed using gene-specific primers and TB Green™ Premix Taq™ Ⅱ (Tli RNaseH Plus; Takara, Shiga Japan), as per the manufacturer's instructions, and normalized to the expression level of Tf2b.
2.3. Statistical analysis
An unpaired Student's t-test was used for statistical analyses. The results are expressed as mean ± SEM, and ∗p < 0.05 and ∗∗p < 0.01 were considered as being indicative of statistically significant differences.
3. Results
3.1. Generation of smaller adipocytes in the iWAT of HFD-fed male mice
To investigate the effect of HFD on the proliferative potential and differentiation capacity of PDGFRα+ APs, we used a PDGFRα-GFP-Cre-ERT2 knock-in (KI/+) mouse model (Figure 1A). Both male and female HFD-fed mice showed similar BW gain and a significant increase in weight in both gWAT and iWAT compared with control NC-fed mice (Supplementary Figs. S1A–S1C). We found that HFD-fed mice consumed lower amounts of food than NC-fed mice, although their caloric intake was comparable (Supplementary Fig. S2A). Overall, our findings revealed that caloric intake from HFD significantly increased BW and depot weight in both male and female mice. Our histological analysis revealed an increased number of smaller adipocytes in iWAT compared with that in gWAT in male mice fed NC or HFD (Figure 1B); however, no such difference was observed in female mice (Figure 1C). Consistent with histological data, the number of larger adipocytes was higher in the gWAT than in the iWAT of male mice; however, an almost similar pattern was observed in the depots of HFD-fed female mice (Supplementary Fig. S2B). We hypothesize that the APs in the iWAT of HFD-fed male mice showed a greater proliferative and differentiation potential than the APs in the gWAT of HFD-fed male mice.
3.2. Newly formed APs proliferate in the iWAT of HFD-fed male mice
To investigate the role of PDGFRα+ APs in HFD-induced adipogenesis, we generated genetically engineered KI/td mice by crossing KI/+ mice with Rosa26-td-Tomato mice (Figure 1D). We administered TAM orally at 225 mg/kg BW for 5 consecutive days (Supplementary Fig. S3A) and found that TAM administration did not alter the BW (Supplementary Fig. S3B). Then, we confirmed the recombination efficiency (46.3% in gWAT and 52% in iWAT) using immunohistochemistry (% was calculated using the formula given in the Methods section) (Figure 1E). We also confirmed the recombination efficiency by flow cytometry analysis (42.35% in gWAT and 43.35% in iWAT) (Figure 1F,G).
To investigate the effect of HFD on the number of PDGFRα+ APs, we fed KI/td mice either HFD or NC for 8 weeks after TAM administration. HFD feeding significantly increased the fat depot percentage relative to BW, regardless of sex, compared with NC feeding (Figure 1H–J). Furthermore, iWAT restrained weight gain compared with gWAT (Figure 1I,J).
Next, we performed flow cytometry analysis to evaluate the number of lineage-negative (CD31−CD45−), Sca1+PDGFRα+, and tdTomato+ (tdTomato+ APs) populations. The gating strategy is shown in Supplementary Figs. S3C and S3D. The number of tdTomato+ APs significantly increased in the gWAT and iWAT of HFD-fed mice, regardless of their sex (Figure 1K, L and Supplementary Figs. S4A and S4B). These data also indicate that in HFD-fed male mice, the iWAT has a higher number of tdTomato+ APs than the gWAT (Figure 1K), suggesting that HFD contributes to the increase in tdTomato+ APs in iWAT.
To further investigate the proliferative potential of newly formed tdTomato+ APs, we stained the paraffin sections of WAT with anti-Ki67 and anti-tdTomato antibodies and found that the percentage of Ki67+/tdTomato+ double-positive cells was significantly higher in iWAT than in gWAT of both male and female mice fed HFD for 8 weeks (Figure 2A,C, and Supplementary Figs. S5A and S5B). Next, we injected HFD-fed KI/td male mice with EdU to trace its cellular uptake and found that EdU uptake was significantly increased in the tdTomato+ cells of iWAT compared with that of gWAT (Figure 2B,D), indicating that newly formed tdTomato+ APs proliferate in response to HFD. Overall, our results suggest that in male mice, APs in iWAT have more proliferative capacity than those in gWAT.
3.3. de novo adipogenesis in the iWAT of HFD-fed male mice
To investigate de novo adipogenesis in HFD-fed mice, we stained paraffin sections of WAT with anti-perilipin and anti-tdTomato antibodies (Figure 3). We found that tdTomato+ APs significantly differentiated into tdTomato-labeled adipocytes in the gWAT and iWAT of HFD-fed mice, irrespective of the sex of the animals (Figure 3A,C, and Supplementary Figs. S6A and S6B). Upon HFD feeding, the percentage of newly generated tdTomato+/perilipin+ adipocytes increased in male mice (from 15.1% to 34.4% in gWAT and from 13.0% to 44.1% in iWAT) (Figure 3B). In female mice, the percentage of tdTomato+ adipocytes increased from 14.8% to 28.5% in gWAT and from 5.8% to 29.9% in iWAT (Figure 3D). Next, to investigate the contribution of hyperplasia in WAT expansion, we performed correlation-comparison analysis between % de novo adipogenesis and WAT depot as % BW. In male mice, we found that the correlation was stronger in the iWAT than in the gWAT (Figure 4A); however, no such difference was observed in female mice (Figure 4B). Our data clearly demonstrate that de novo adipogenesis contributes more to iWAT expansion than to gWAT expansion, suggesting that iWAT expands through hyperplasia in response to HFD stimuli.
3.4. tdTomato+APs in iWAT underwent hyperplasia and tdTomato+APs in gWAT underwent hypertrophy in HFD-fed male mice
We analyzed the size of the pre-existing adipocytes and newly generated adipocytes in both fat depots (Figure 3A,C). We considered cells with tdTomato+/perilipin+ co-immunofluorescence as newly generated tdTomato+ adipocytes. tdTomato−/perilipin+ adipocytes consisted of pre-existing adipocytes as well as newly generated tdTomato− adipocytes derived from non-recombined APs (Supplementary Fig. S7). Regarding adipose depots in male mice, adipocyte size frequency histogram data showed that HFD increases the generation of smaller adipocytes in iWAT and that of larger adipocytes in gWAT (Figure 5A). In contrast, almost similar patterns were observed in the two fat depots in female mice (Figure 5B). Gene expression analysis further revealed the downregulated expression of inflammatory marker genes in iWAT compared with that observed in gWAT (Supplementary Fig. S8), suggesting that iWAT is less inflammatory. These data support our hypothesis that in male mice, iWAT undergoes hyperplasia due to the recruitment of newly generated adipocytes, whereas gWAT mainly undergoes hypertrophy through the enlargement of the pre-existing adipocytes. Interestingly, the size of the tdTomato− adipocyte, which may contain newly generated adipocytes (derived from non-labeled APs), was larger than that of the tdTomato+ adipocyte.
To investigate the intrinsic differences between the APs in the two WAT depots in HFD-fed male mice, we sorted tdTomato+ and tdTomato− APs using fluorescence-activated cell sorting (FACS) (Figure 6A) and the sorted cells were subjected to gene expression analysis. Isolated tdTomato + APs showed higher mRNA levels of tdTomato and Pdgfrα (Figure 6B,C). Interestingly, tdTomato + APs showed higher expression levels of Dpp4 and Pi16 than tdTomato− APs, and the expression of these genes was significantly higher in the iWAT than in the gWAT of male mice fed HFD for 8 weeks (Figure 6D,E). As we have already mentioned that iWAT possesses large numbers of tdToamao+ cells, taken together these data suggest that the APs in iWAT are highly proliferative in response to HFD stimuli. By contrast, tdTomato− APs showed higher expression levels of Icam1 and Pparγ, suggesting that tdTomato− APs are more committed to an adipogenic fate (Figure 6F,G).
4. Discussion
The ability of APs to proliferate and undergo adipogenesis during obesity is important to maintain a healthy expansion of WAT. A previous report showed that only APs in the iWAT had proliferative potential in HFD-fed mice [25]. Fate-mapping studies utilizing different inducible Cre-driver mice have shown that the APs in the iWAT of HFD-fed male mice have little or no proliferative potential [5,6,[26], [27], [28]]. The discrepant results can be explained by the different experimental models of transgenic mice used in different studies. Wang et al. used AdipoChaser mice [27] and Jeffery et al. used Adiponectin-creER; mTmG mice [6,28] to show that HFD-induced adipogenesis occurs only in gWAT. Another report used PDGFRα-MerCreMer-Rosa26-tdTomato mice [26] and showed greater labeling efficiency in gWAT than in iWAT, supporting the hypothesis that only the gWAT in male mice can differentiate. Vishvanath et al. used PDGFRβrtTA;TRE-Cre; mTmG mice [5] and found that 4 weeks of HFD induces adipogenesis in gWAT but not in iWAT. They also showed that the number of APs increased in both fat depots (gWAT and iWAT). However, whether PDGFRβ+ APs expressed PDGFRα was not discussed. Gao et al. also used PDGFRβ-Cre mice and demonstrated that PDGFRβ+ APs derived from PDGFRα+ cells in iWAT contribute to HFD-induced adipogenesis [19]. Han et al. provided key evidence that PDGFRα single-positive and PDGFRα/PDGFRβ double-positive APs, but not PDGFRβ single-positive APs, contribute to cold-induced adipogenesis [34]. Although the number of PDGFRα/PDGFRβ double-positive cells was less than that of PDGFRα single-positive and PDGFRβ single-positive cells, the adipogenic potential of PDGFRα/PDGFRβ double-positive cells was comparable with that of PDGFRα single-positive APs, showing that PDGFRα/PDGFRβ double-positive cells have higher potential for beige adipogenesis. However, they did not analyze how these APs contributed to HFD-induced adipogenesis. Another group used PDGFRα-Cre-ERT2 mice generated by Rivers et al. [47] and showed that PDGFRα+ APs did not participate in adult adipogenesis [48]. These studies were performed in different laboratories using different doses of TAM for recombination and with distinct Cre-drivers for producing transgenic models. This prompted us to examine the proliferative and adipogenic capacity of iWAT APs utilizing PDGFRα-GFP-Cre-ERT2 knock-in (KI/+) mice. Our knock-in Cre-driver mouse model showed higher labeling efficiency of APs in both iWAT and gWAT than the mouse models reported by River et al. and Ding et al. [47,49]. However, the precise reason for discrepant labeling efficiency of APs within the WAT depots remains unknown.
Taking advantage of single-cell RNA sequence analysis, studies have revealed that DPP4+ and Pi16+ APs have a high proliferative potential [[30], [31], [32], [33]]. Han et al. reported that PDGFRα single-positive APs showed high expression of Dpp4 and Pi16 and contributed to cold-induced adipogenesis. Moreover, PDGFRα/PDGFRβ double-positive APs contributed to cold-induced adipogenesis to a similar extent, although their number was smaller. However, PDGFRα/PDGFRβ double-positive APs showed an upregulation of Lpl and Fabp4 expression, which indicates that these APs are more committed to adipogenesis [34]. Consistent with this, our gene expression analysis revealed higher expression of Pdgfrα, Dpp4, and Pi16 in FACS-purified tdTomato+ APs than in non-labeled (tdTomato−) APs, whereas tdTomato− (non-recombined) APs showed higher expression of Icam1 and Pparγ. Collectively, these results indicate that iWAT has an abundance of a subtype of APs with higher expression of Pdgfrα, Dpp4, and Pi16 and a higher proliferative potential. Thus, compared with gWAT expansion, iWAT expansion occurs through hyperplasia.
Previously, we and others showed that the generation of smaller adipocytes contributed to insulin sensitivity [[40], [41], [42],[50], [51], [52], [53]]. Adipocyte size has been reported to be directly related to the secretory profile as well as adipocyte functions [25,54]. The average size of newly formed and pre-existing adipocytes within both the WAT depots in mice fed HFD for 8 weeks is comparable in both sexes [6]. According to another study, newly formed adipocytes from PDGFRβ+ APs were larger in size than pre-existing adipocytes [19]; in contrast, we found that newly generated adipocytes were smaller in size compared with pre-existing adipocytes. Our data also showed that iWAT had a higher percentage of smaller, newly generated adipocytes than gWAT in male mice fed HFD for 8 weeks.
Our study has some limitations; the recombination efficiency is about 42–43% and tdTomato− non-labeled adipocytes consisted of both pre-existing adipocytes and adipocytes derived from non-recombined APs, which have lower Pdgfrα expression. However, we believe that our argument is strong with key evidence that iWAT is rich in APs with higher proliferative and adipogenic capacity, thus resulting in hyperplasia under HFD conditions.
In conclusion, our findings reveal that iWAT APs of male HFD-fed mice proliferate and differentiate into newly generated, smaller adipocytes to a greater extent than that observed in gWAT APs. We believe that iWAT is a potential target for the development of drugs for treating obesity-induced insulin resistance.
Author contributions
M.B. and A.N. designed and executed the experiments. K.T., M.R.A., and Y.I. helped in performing the in vivo experiments. A.N., Y.W., T.K., and J.L. assisted in genotyping and reviewing the manuscript. S.F., J.I., T.N., and K.Y. critically reviewed and revised the manuscript. K.I., M.H., and T.E. provided the founder mice. K.T. conceived the idea of the study and supervised the project. M.B. and A.N. contributed to this study equally.
Acknowledgments
This work was supported by the Young Research Grant from the Japan Diabetes Society (to A.N). This research was partially supported by Moonshot R&D Grant Number JPMJMS2021. This work was also supported by Grants-in-Aid for Scientific Research (20K08882 to K.T.), the Mitsubishi Foundation/Research Grants in the Natural Science (2019), a grant from the Japan Diabetes Foundation (2020), a grant from the First Bank of Toyama Foundation (2020), a grant from the Uehara Memorial Foundation (2018), and a grant from the Naito Foundation (2018) (to K.T). We thank the Otsuka Toshimi Scholarship Foundation for the financial support provided to M.B. The authors thank Yurie Iwakuro and Takeshi Nishida for excellent technical assistance. We would like to thank Editage (www.editage.com) for English language editing. Prof. Kazuyuki Tobe is the guarantor of this work and takes responsibility for the integrity of the data and the accuracy of data analysis.
Footnotes
Supplemental information, including details of reagents, qPCR primers and antibodies (Table 1), and supplementary figures can be found in the online at https://doi.org/10.1016/j.molmet.2021.101328.
Contributor Information
Allah Nawaz, Email: nawaz@med.u-toyama.ac.jp.
Kazuyuki Tobe, Email: tobe@med.u-toyama.ac.jp.
Conflict of interest
None declared.
Appendix A. Supplementary data
The following is the Supplementary data to this article:
References
- 1.Berry R., Jeffery E., Rodeheffer M.S. Weighing in on adipocyte precursors. Cell Metabolism. 2014;19(1):8–20. doi: 10.1016/j.cmet.2013.10.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Ghaben A.L., Scherer P.E. Adipogenesis and metabolic health. Nature Reviews Molecular Cell Biology. 2019;20(4):242–258. doi: 10.1038/s41580-018-0093-z. [DOI] [PubMed] [Google Scholar]
- 3.Rodeheffer M.S., Birsoy K., Friedman J.M. Identification of white adipocyte progenitor cells in vivo. Cell. 2008;135(2):240–249. doi: 10.1016/j.cell.2008.09.036. [DOI] [PubMed] [Google Scholar]
- 4.Sun K., Kusminski C.M., Scherer P.E. Adipose tissue remodeling and obesity. Journal of Clinical Investigation. 2011;121(6):2094–2101. doi: 10.1172/JCI45887. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Vishvanath L., MacPherson K.A., Hepler C., Wang Q.A., Shao M., Spurgin S.B. Pdgfrβ+ mural preadipocytes contribute to adipocyte hyperplasia induced by high-fat-diet feeding and prolonged cold exposure in adult mice. Cell Metabolism. 2016;23(2):350–359. doi: 10.1016/j.cmet.2015.10.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Jeffery E., Wing A., Holtrup B., Sebo Z., Kaplan J.L., Saavedra-Peña R. The adipose tissue microenvironment regulates depot-specific adipogenesis in obesity. Cell Metabolism. 2016;24(1):142–150. doi: 10.1016/j.cmet.2016.05.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Lee J.J., Beretvas S.N., Freeland-Graves J.H. Abdominal adiposity distribution in diabetic/prediabetic and nondiabetic populations: a meta-analysis. Journal of Obesity. 2014;(6):697264. doi: 10.1155/2014/697264. 2014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Coutinho T., Goel K., Corrêa de Sá D., Kragelund C., Kanaya A.M., Zeller M. Central obesity and survival in subjects with coronary artery disease: a systematic review of the literature and collaborative analysis with individual subject data. Journal of the American College of Cardiology. 2011;57(19):1877–1886. doi: 10.1016/j.jacc.2010.11.058. [DOI] [PubMed] [Google Scholar]
- 9.Nazare J.A., Smith J.D., Borel A.L., Haffner S.M., Balkau B., Ross R. Ethnic influences on the relations between abdominal subcutaneous and visceral adiposity, liver fat, and cardiometabolic risk profile: the International Study of Prediction of Intra-Abdominal Adiposity and its Relationship with Cardiometabolic Risk/Intra-Abdominal Adiposity. American Journal of Clinical Nutrition. 2012;96(4):714–726. doi: 10.3945/ajcn.112.035758. [DOI] [PubMed] [Google Scholar]
- 10.Phillips L.K., Prins J.B. The link between abdominal obesity and the metabolic syndrome. Current Hypertension Reports. 2008;10(2):156–164. doi: 10.1007/s11906-008-0029-7. [DOI] [PubMed] [Google Scholar]
- 11.Pischon T., Boeing H., Hoffmann K., Bergmann M., Schulze M.B., Overvad K. General and abdominal adiposity and risk of death in Europe. New England Journal of Medicine. 2008;359(20):2105–2120. doi: 10.1056/NEJMoa0801891. [DOI] [PubMed] [Google Scholar]
- 12.Wormser D., Kaptoge S., Di Angelantonio E., Wood A.M., Pennells L., Thompson A. Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. Lancet. 2011;377(9771):1085–1095. doi: 10.1016/S0140-6736(11)60105-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Hirsch J., Batchelor B. Adipose tissue cellularity in human obesity. Journal of Clinical Endocrinology & Metabolism. 1976;5(2):299–311. doi: 10.1016/s0300-595x(76)80023-0. [DOI] [PubMed] [Google Scholar]
- 14.Hirsch J., Knittle J.L. Cellularity of obese and nonobese human adipose tissue. Federation Proceedings. 1970;29(4):1516–1521. [PubMed] [Google Scholar]
- 15.Gesta S., Tseng Y.H., Kahn C.R. Developmental origin of fat: tracking obesity to its source. Cell. 2007;131(2):242–256. doi: 10.1016/j.cell.2007.10.004. [DOI] [PubMed] [Google Scholar]
- 16.Tran T.T., Yamamoto Y., Gesta S., Kahn C.R. Beneficial effects of subcutaneous fat transplantation on metabolism. Cell Metabolism. 2008;7(5):410–420. doi: 10.1016/j.cmet.2008.04.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Thörne A., Lönnqvist F., Apelman J., Hellers G., Arner P. A pilot study of long-term effects of a novel obesity treatment: omentectomy in connection with adjustable gastric banding. International Journal of Obesity and Related Metabolic Disorders. 2002;26(2):193–199. doi: 10.1038/sj.ijo.0801871. [DOI] [PubMed] [Google Scholar]
- 18.Arner P., Andersson D.P., Thörne A., Wirén M., Hoffstedt J., Näslund E. Variations in the size of the major omentum are primarily determined by fat cell number. Journal of Clinical Endocrinology & Metabolism. 2013;98(5):E897–E901. doi: 10.1210/jc.2012-4106. [DOI] [PubMed] [Google Scholar]
- 19.Gao Z., Daquinag A.C., Su F., Snyder B., Kolonin M.G. PDGFRα/PDGFRβ signaling balance modulates progenitor cell differentiation into white and beige adipocytes. Development. 2018;145(1) doi: 10.1242/dev.155861. dev.155861. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Ibrahim M.M. Subcutaneous and visceral adipose tissue: structural and functional differences. Obesity Reviews. 2010;11(1):11–18. doi: 10.1111/j.1467-789X.2009.00623.x. [DOI] [PubMed] [Google Scholar]
- 21.Klöting N., Fasshauer M., Dietrich A., Kovacs P., Schön M.R., Kern M. Insulin-sensitive obesity. American Journal of Physiology - Endocrinology And Metabolism. 2010;299(3):E506–E515. doi: 10.1152/ajpendo.00586.2009. [DOI] [PubMed] [Google Scholar]
- 22.Kim J.Y., van de Wall E., Laplante M., Azzara A., Trujillo M.E., Hofmann S.M. Obesity-associated improvements in metabolic profile through expansion of adipose tissue. Journal of Clinical Investigation. 2007;117(9):2621–2637. doi: 10.1172/JCI31021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Karastergiou K., Smith S.R., Greenberg A.S., Fried S.K. Sex differences in human adipose tissues - the biology of pear shape. Biology of Sex Differences. 2012;3(1):13. doi: 10.1186/2042-6410-3-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Shi H., Seeley R.J., Clegg D.J. Sexual differences in the control of energy homeostasis. Frontiers in Neuroendocrinology. 2009;30(3):396–404. doi: 10.1016/j.yfrne.2009.03.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Joe A.W., Yi L., Even Y., Vogl A.W., Rossi F.M. Depot-specific differences in adipogenic progenitor abundance and proliferative response to high-fat diet. Stem Cells. 2009;27(10):2563–2570. doi: 10.1002/stem.190. [DOI] [PubMed] [Google Scholar]
- 26.Cattaneo P., Mukherjee D., Spinozzi S., Zhang L., Larcher V., Stallcup W.B. Parallel lineage-tracing studies establish fibroblasts as the prevailing in vivo adipocyte progenitor. Cell Reports. 2020;30(2):571–582. doi: 10.1016/j.celrep.2019.12.046. e2. [DOI] [PubMed] [Google Scholar]
- 27.Wang Q.A., Tao C., Gupta R.K., Scherer P.E. Tracking adipogenesis during white adipose tissue development, expansion and regeneration. Nature Medicine. 2013;19(10):1338–1344. doi: 10.1038/nm.3324. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Jeffery E., Church C.D., Holtrup B., Colman L., Rodeheffer M.S. Rapid depot-specific activation of adipocyte precursor cells at the onset of obesity. Nature Cell Biology. 2015;17(4):376–385. doi: 10.1038/ncb3122. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Berry R., Rodeheffer M.S. Characterization of the adipocyte cellular lineage in vivo. Nature Cell Biology. 2013;15(3):302–308. doi: 10.1038/ncb2696. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Merrick D., Sakers A., Irgebay Z., Okada C., Calvert C., Morley M.P. Identification of a mesenchymal progenitor cell hierarchy in adipose tissue. Science. 2019;364(6438) doi: 10.1126/science.aav2501. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Burl R.B., Ramseyer V.D., Rondini E.A., Pique-Regi R., Lee Y.H., Granneman J.G. Deconstructing adipogenesis induced by β3-adrenergic receptor activation with single-cell expression profiling. Cell Metabolism. 2018;28(2):300–309. doi: 10.1016/j.cmet.2018.05.025. e4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Hepler C., Shan B., Zhang Q., Henry G.H., Shao M., Vishvanath L. Identification of functionally distinct fibro-inflammatory and adipogenic stromal subpopulations in visceral adipose tissue of adult mice. Elife. 2018;7 doi: 10.7554/eLife.39636. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Schwalie P.C., Dong H., Zachara M., Russeil J., Alpern D., Akchiche N. A stromal cell population that inhibits adipogenesis in mammalian fat depots. Nature. 2018;559(7712):103–108. doi: 10.1038/s41586-018-0226-8. [DOI] [PubMed] [Google Scholar]
- 34.Han X., Zhang Z., He L., Zhu H., Li Y., Pu W. A suite of new Dre recombinase drivers markedly expands the ability to perform intersectional genetic targeting. Cell Stem Cell. 2021;28(6):1160–1176. doi: 10.1016/j.stem.2021.01.007. e7. [DOI] [PubMed] [Google Scholar]
- 35.Miwa H., Era T. Generation and characterization of PDGFRα-GFPCreERT2 knock-In mouse line. Genesis. 2015;53(5):329–336. doi: 10.1002/dvg.22853. [DOI] [PubMed] [Google Scholar]
- 36.Kuwano T., Izumi H., Aslam M.R., Igarashi Y., Bilal M., Nishimura A. Generation and characterization of a Meflin-CreERT2 transgenic line for lineage tracing in white adipose tissue. PloS One. 2021;16(3) doi: 10.1371/journal.pone.0248267. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Horikawa S., Ishii Y., Hamashima T., Yamamoto S., Mori H., Fujimori T. PDGFRα plays a crucial role in connective tissue remodeling. Scientific Reports. 2015;5:17948. doi: 10.1038/srep17948. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Bagchi D.P., MacDougald O.A. Identification and dissection of diverse mouse adipose depots. Journal of Visualized Experiments. 2019;149 doi: 10.3791/59499. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Tchkonia T., Thomou T., Zhu Y., Karagiannides I., Pothoulakis C., Jensen M.D. Mechanisms and metabolic implications of regional differences among fat depots. Cell Metabolism. 2013;17(5):644–656. doi: 10.1016/j.cmet.2013.03.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Fujisaka S., Usui I., Bukhari A., Ikutani M., Oya T., Kanatani Y. Regulatory mechanisms for adipose tissue M1 and M2 macrophages in diet-induced obese mice. Diabetes. 2009;58(11):2574–2582. doi: 10.2337/db08-1475. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Fujisaka S., Usui I., Ikutani M., Aminuddin A., Takikawa A., Tsuneyama K. Adipose tissue hypoxia induces inflammatory M1 polarity of macrophages in an HIF-1α-dependent and HIF-1α-independent manner in obese mice. Diabetologia. 2013;56(6):1403–1412. doi: 10.1007/s00125-013-2885-1. [DOI] [PubMed] [Google Scholar]
- 42.Nawaz A., Aminuddin A., Kado T., Takikawa A., Yamamoto S., Tsuneyama K. CD206(+) M2-like macrophages regulate systemic glucose metabolism by inhibiting proliferation of adipocyte progenitors. Nature Communications. 2017;8(1):286. doi: 10.1038/s41467-017-00231-1. 286. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Igarashi Y., Nawaz A., Kado T., Bilal M., Kuwano T., Yamamoto S. Partial depletion of CD206-positive M2-like macrophages induces proliferation of beige progenitors and enhances browning after cold stimulation. Scientific Reports. 2018;8(1):14567. doi: 10.1038/s41598-018-32803-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Watanabe Y., Fujisaka S., Ikeda K., Ishikawa M., Yamada T., Nawaz A. Gut microbiota, determined by dietary nutrients, drive modification of the plasma lipid profile and insulin resistance. iScience. 2021;24(5):102445. doi: 10.1016/j.isci.2021.102445. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Nawaz A., Mehmood A., Kanatani Y., Kado T., Igarashi Y., Takikawa A. Sirt1 activator induces proangiogenic genes in preadipocytes to rescue insulin resistance in diet-induced obese mice. Scientific Reports. 2018;8(1):18–29773. doi: 10.1038/s41598-018-29773-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Takikawa A., Mahmood A., Nawaz A., Kado T., Okabe K., Yamamoto S. HIF-1alpha in myeloid cells promotes adipose tissue remodeling toward insulin resistance. Diabetes. 2016;65(12):3649–3659. doi: 10.2337/db16-0012. [DOI] [PubMed] [Google Scholar]
- 47.Rivers L.E., Young K.M., Rizzi M., Jamen F., Psachoulia K., Wade A. PDGFRA/NG2 glia generate myelinating oligodendrocytes and piriform projection neurons in adult mice. Nature Neuroscience. 2008;11(12):1392–1401. doi: 10.1038/nn.2220. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Shin S., Pang Y., Park J., Liu L., Lukas B.E., Kim S.H. Dynamic control of adipose tissue development and adult tissue homeostasis by platelet-derived growth factor receptor alpha. Elife. 2020;9 doi: 10.7554/eLife.56189. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Ding G., Tanaka Y., Hayashi M., Nishikawa S., Kataoka H. PDGF receptor alpha+ mesoderm contributes to endothelial and hematopoietic cells in mice. Developmental Dynamics. 2013;242(3):254–268. doi: 10.1002/dvdy.23923. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Nawaz A., Kado T., Igaashi Y., Yagi K., Usui I., Fujisaka S. Adipose tissue-resident macrophages and obesity. RADS Journal of Pharmacy and Pharmaceutical Sciences. 2017;5(3):57–62. [Google Scholar]
- 51.Fujisaka S., Usui I., Nawaz A., Takikawa A., Kado T., Igarashi Y. M2 macrophages in metabolism. Diabetology International. 2016;7(4):342–351. doi: 10.1007/s13340-016-0290-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Nawaz A., Tobe K. M2-like macrophages serve as a niche for adipocyte progenitors in adipose tissue. Journal of Diabetes Investigation. 2019;10(6):1394–1400. doi: 10.1111/jdi.13114. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Okuno A., Tamemoto H., Tobe K., Ueki K., Mori Y., Iwamoto K. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats. Journal of Clinical Investigation. 1998;101(6):1354–1361. doi: 10.1172/JCI1235. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Khan T., Muise E.S., Iyengar P., Wang Z.V., Chandalia M., Abate N. Metabolic dysregulation and adipose tissue fibrosis: role of collagen VI. Molecular and Cellular Biology. 2009;29(6):1575–1591. doi: 10.1128/MCB.01300-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.